Jubilant Pharma redeems Senior Notes aggregating USD 200 mn

Image
Capital Market
Last Updated : Aug 19 2022 | 2:50 PM IST
Jubilant Pharmova announced that its wholly owned subsidiary, Jubilant Pharma, Singapore has on 18 August 2022 redeemed the principal amount of US$200,000,000 6% Senior Notes Due in 2024 at a redemption price of 103% together with the accrued interest.

After the said redemption, the Notes have been paid in full and no amount remains outstanding under the Notes. Further, Jubilant Pharma does not have any other securities listed on SGX.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 19 2022 | 2:39 PM IST

Next Story